---
title: 'Evaluation of four chatbots in autoimmune liver disease: A comparative analysis'
date: '2024-08-15'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39147133/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240816182134&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: Chatbots hold promise in AILD support, but our study underscores
  key areas for improvement. Refinement is needed in providing specific advice, accuracy,
  and focused up-to-date information. Addressing these shortcomings is essential for
  enhancing the utility of chatbots in AILD management, guiding future development,
  and ensuring their effectiveness as clinical decision-support ...'
disable_comments: true
---
CONCLUSIONS: Chatbots hold promise in AILD support, but our study underscores key areas for improvement. Refinement is needed in providing specific advice, accuracy, and focused up-to-date information. Addressing these shortcomings is essential for enhancing the utility of chatbots in AILD management, guiding future development, and ensuring their effectiveness as clinical decision-support ...